Khiron Life Sciences Corp. (KHRNF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 18, 2025
Khiron Life Sciences Market Cap
Khiron Life Sciences has a market cap or net worth of $232.00 as of August 22, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
232.00
Enterprise Value
n/a
Revenue
11.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 29, 2018, Khiron Life Sciences's market cap has decreased from 39.50M to 232.00, a decrease of -100.00%. That is a compound annual growth rate of -81.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 232.00 | - |
| Dec 31, 2024 | 232.00 | -99.97% |
| Dec 29, 2023 | 697.23K | -92.30% |
| Dec 30, 2022 | 9.06M | -69.35% |
| Dec 31, 2021 | 29.55M | -33.80% |
| Dec 31, 2020 | 44.64M | -52.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 367.18M |